Evelo Biosciences, Inc. (EVLO)
OTCMKTS: EVLO · Delayed Price · USD
0.0457
+0.0015 (3.39%)
Apr 25, 2024, 11:33 AM EDT - Market closed

Evelo Biosciences Market Cap

Evelo Biosciences has a market cap or net worth of $858.97 thousand as of April 26, 2024. Its market cap has decreased by -99.64% in one year.

Market Cap
858.97K
Enterprise Value
17.54M
1-Year Change
-99.64%
Ranking
n/a
Category
Stock Price
$0.05

Market Cap Chart

Since May 9, 2018, Evelo Biosciences's market cap has decreased from $517.90M to $858.97K, a decrease of -99.83%. That is a compound annual growth rate of -68.16%.

History

DateMarket Cap% Change
Dec 11, 20236.00M-14.29%
Dec 8, 20237.00M9.38%
Dec 7, 20236.40M-7.25%
Dec 6, 20236.90M-5.48%
Dec 5, 20237.30M-3.95%
Dec 4, 20237.60M1.33%
Dec 1, 20237.50M-1.32%
Nov 30, 20237.60M-2.56%
Nov 29, 20237.80M-
Nov 28, 20237.80M-2.50%
Nov 27, 20238.00M-12.09%
Nov 24, 20239.10M-20.87%
Nov 22, 202311.50M3.60%
Nov 21, 202311.10M2.78%
Nov 20, 202310.80M14.89%
Nov 17, 20239.40M-32.37%
Nov 16, 202313.90M65.48%
Nov 15, 20238.40M29.23%
Nov 14, 20236.50M4.84%
Nov 13, 20236.20M6.90%
Nov 10, 20235.80M-6.45%
Nov 9, 20236.20M-
Nov 8, 20236.20M-3.13%
Nov 7, 20236.40M-
Nov 6, 20236.40M-20.00%
View and export this data all the way back to 2018. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 699.60B
Novo Nordisk 572.23B
UnitedHealth Group 457.02B
Johnson & Johnson 352.59B
Merck & Co. 332.43B
AbbVie 280.74B
AstraZeneca 233.51B
Thermo Fisher 218.86B
Market Cap Rankings